Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Costco Faces Class Action Lawsuit Over Tariff Refunds as Supreme Court Strikes Down Trump's IEEPA Tariffs 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
UBS Seeks Legal Protection Over Credit Suisse's Nazi-Era Banking Activities 
DOJ Backs Jeanine Pirro-Led Investigation Into Federal Reserve Chair Jerome Powell 
DOJ Antitrust Chief Rejects Political Fast-Track for Paramount-Skydance Deal 
California Court Rejects xAI Bid to Block AI Data Transparency Law 
ICE Arrests Colombian Journalist in Tennessee, Trump Administration Says She Will Receive Due Process 
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology 
Federal Judge Orders Refund of Trump’s Emergency Tariffs, Potentially Returning Up to $182 Billion 
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
Supreme Court Blocks California Transgender Student Privacy Laws in 6-3 Decision 
Federal Judge Blocks Virginia Social Media Age Verification Law Over First Amendment Concerns 
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Microsoft Backs Anthropic in Legal Fight Against Pentagon's AI Blacklist 
For decades, cannabis or marijuana as it is more commonly known has been treated as an illegal substance that could land offenders in prison for a long time. After the movement to make marijuana legal gained steam, several U.S. states have since changed their tune and legalized its use. Now, a pharmaceutical company is considering developing drugs with cannabis as one of the main ingredients.
The drug company in question is GrowBlox Life Sciences LLC and it recently announced that it will be creating a new medication for curing and preventing cardiovascular diseases using marijuana as one of the ingredients, Futurism reports. One of the main driving forces behind the move is Dr. Alexander Stokes from the University of Hawaii.
In 2015, Stokes received a patent for developing a therapy method involving the treatment of heart diseases with cannabis as the principal component. When asked about it a year ago, Stokes explained that the main problems that cause heart disease in the first place have to do with increasing the strain placed on it. By giving the heart a bit of support, this workload can be redistributed.
“Many types of diseases ultimately affect the heart by making it work harder,” Stokes had said at the time. “The heart muscle compensates by getting bigger (cardiac hypertrophy). The heart becomes stiffer and less functional and eventually starts to fail. We have a way of protecting the heart with a completely new therapeutic approach—a therapy that allows the heart to compensate for the extra work it needs to perform, without losing function and failing.”
The main idea is to basically bind the receptor called TRPV1 with the cannabinoid in marijuana. Since TRPV1 is considered one of the main things that ultimately contribute to heart failure, keeping it in check will go a long way towards preventing a heart attack.
